Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.

PLoS One · 2023 · PMC9873150 · PMID 36693058

Europe PMC DOI

hedged sentence

0.0320

closest p · 0.6× alpha

0.0320

boldest claim

The sentences

highly significantp = 0.032actually significant

We observed highly significant differences of the plateau values between Group S and Group M individuals both for the VITORS S-IgG values and for the cPass sVNT titers ( p = 0.032 and p <0.0001 by Wilcoxon test, respectively).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.